Innovative Grade US Origin Mouse Plasma - CD-1 Reference 11-19-14

Posted by Leanne Kodsman on

Innovative Research's Innovative Grade US Origin Mouse Plasma - CD-1 was recently used in the following study:

Thermosensitive Liposome Formulated Indocyanine Green for Near-Infrared Triggered Photodynamic Therapy: In Vivo Evaluation for Triple-Negative Breast Cancer

CS Shemesh, D Moshkelani, H Zhang - Pharmaceutical Research, 2014
Heparinized mouse plasma was purchased from Innovative Research (Novi, MI). ... Furthermore,liposo- mal encapsulation of photosensitizers other than ICG have been attempted and evaluated in vitro and ex vivo by other researchers for cancer treatment, which have shown to...

  • Tags: Animal Plasma, Innovative Grade US Origin Mouse CD1 Plasma

    • The next big thing: it's what you do. The biological research materials you need to discover it? That's what we do! We love seeing how our products are being used in real-life applications and contributing to scientific acheivements every day. With thousands of published references and decades of proven results, you can count on us to help you source the high-quality biomaterials you need that will deliver reliable, consistent results - kit to kit, lot to lot, all study long. So what are you waiting for? All great discoveries start somewhere... yours starts with Innovative Research! Get in touch with our team today!


    Related Posts

    Unlock Your Research Potential with Our Premier E. Coli Competent Cells
    Dive into the world of unparalleled genetic research with our diverse lineup of E. coli...
    Read the Article
    Easy as PAI(-1): Celebrate Pi Day with Cutting-Edge Monoclonal Antibodies from Innovative Research
    In the ever-evolving landscape of molecular biology, precision tools are essential for ...
    Read the Article
    Revolutionizing Diabetes Treatment: Genetically Engineered Pseudo-Islets Achieve Insulin Independence
    In a groundbreaking study, researchers have pioneered a diabetes treatment that could r...
    Read the Article

    ← Older Post Newer Post →

    ×